Lasker winner Frank Dixon dies

Frank Dixon, a Lasker winner and founder of the Scripps Research Institute in La Jolla, Calif., died on Friday (February 8) of heart failure. He was 87 years old. Dixon was best known for his work showing that immunologic responses can cause harm, including kidney and cardiovascular diseases, among others. That research earned him the 1975 Albert Lasker Award for Basic Medical Research. Dixon's colleagues remembered him as a "no-nonsense," focused scientist. Dixon was a "very severe, very toug

Written byAlison McCook
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Frank Dixon, a Lasker winner and founder of the Scripps Research Institute in La Jolla, Calif., died on Friday (February 8) of heart failure. He was 87 years old. Dixon was best known for his work showing that immunologic responses can cause harm, including kidney and cardiovascular diseases, among others. That research earned him the 1975 Albert Lasker Award for Basic Medical Research. Dixon's colleagues remembered him as a "no-nonsense," focused scientist. Dixon was a "very severe, very tough man," recalled Argyrios Theofilopoulos, a professor in the department of immunology at Scripps. "He didn't want the small talk or small explanation," Theofilopoulos said. "He wanted the facts and wanted it to be straight." Dixon's focus paid off, Theofilopoulos noted: "He did very elegant and important work." Still, the scientist had moments of softness. He would invite young Theofilopoulos, who worked with Dixon for 20 years, into his office to drink Coca Cola every afternoon. "I found a way to interact with him." Dixon was born in St. Paul, Minnesota in 1920, and completed medical school at the University of Minnesota. After brief stints at Harvard Medical School's department of pathology and the Washington University Medical School in St. Louis, he spent 10 years as the chair of the department of pathology at the University of Pittsburgh School of Medicine. In 1961, Dixon and four colleagues came to La Jolla and to establish the Department of Experimental Pathology at Scripps Clinic and Research Foundation. This would one day become the core of the Scripps Research Institute, now in fourteen laboratory buildings with more than 1,000,000 square feet of space and more than 2,000 professors, postdocs, and other personnel. Early in his career, Dixon developed isotope tracer techniques for studying immunologically important proteins. He used them to study serum sickness, ultimately shedding light on the mechanisms underlying rheumatoid arthritis, vasculitis, and other related diseases. He also investigated the relationship between chronic viral infection and linkurl:autoimmune;http://www.the-scientist.com/article/display/53106/ disease. One of Dixon's papers describing a method using linkurl:trace iodination of proteins;http://www.ncbi.nlm.nih.gov/pubmed/4160044?ordinalpos=266&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum for immunologic studies, published in 1966, has since accumulated 2,700 citations. According to ISI, Dixon wrote nearly 500 papers. Dixon "was always willing to sit down and talk about science," said Charles Cochrane, who joined Dixon at Pittsburgh and moved out with him to Scripps in 1961. "He was an excellent scientist." Dixon is survived by his wife and three children. With reporting from Edyta Zielinska Image: (on homepage, February 11): Dixon (2nd from left), from Scripps
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies